Bioceres Crop Solutions Corp.

General ticker "BIOX" information:

  • Sector: Materials
  • Industry: Chemicals
  • Capitalization: $271.0M (TTM average)

Bioceres Crop Solutions Corp. does not follow the US Stock Market performance with the rate: -21.2%.

Estimated limits based on current volatility of 3.7%: low 1.57$, high 1.69$

Factors to consider:

  • Total employees count: 409 as of 2019
  • Current price 69.6% below estimated low
  • Earnings for 12 months up through Q4 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-06-30 to 2026-06-30

  • 2024-06-30 to 2025-06-30 estimated range: [6.65$, 14.77$]
  • 2025-06-30 to 2026-06-30 estimated range: [5.19$, 11.89$]

Financial Metrics affecting the BIOX estimates:

  • Positive: with PPE of 10000.0 at the end of fiscal year the price was very low
  • Positive: 7.86 < Operating profit margin, % of 9.64
  • Positive: -2.95 < Return on assets ratio (scaled to [-100,100]) of 0.73
  • Positive: Industry inventory ratio change (median), % of -0.32 <= -0.15
  • Positive: 2.97 < Industry operating profit margin (median), % of 3.09
  • Positive: 18.93 < Shareholder equity ratio, % of 36.98 <= 41.86
  • Negative: Investing cash flow per share per price, % of -4.24 <= -0.66
  • Negative: Industry operating cash flow per share per price (median), % of 1.91 <= 5.52
  • Negative: Operating cash flow per share per price, % of 6.16 <= 6.82

Similar symbols

Short-term BIOX quotes

Long-term BIOX plot with estimates

Financial data

YTD 2023-06-30 2024-06-30
Operating Revenue $419.45MM $464.83MM
Operating Expenses $365.26MM $420.01MM
Operating Income $54.18MM $44.82MM
Non-Operating Income $-35.08MM $-34.79MM
Interest Expense $23.79MM $26.87MM
R&D Expense $15.35MM $17.18MM
Income(Loss) $19.11MM $10.04MM
Taxes $-1.07MM $3.78MM
Profit(Loss)* $18.78MM $3.24MM
Stockholders Equity $298.85MM $315.30MM
Inventory $140.57MM $126.22MM
Assets $818.06MM $852.55MM
Operating Cash Flow $2.59MM $41.72MM
Capital expenditure $22.56MM $22.78MM
Investing Cash Flow $-25.73MM $-28.73MM
Financing Cash Flow $32.95MM $-10.06MM
Earnings Per Share** $0.30 $0.05

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.